Radmila Kancheva

Dr. Radmila Kancheva


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Neuroscience
Verified
Journal Article
Closed access
RKRadmila Kancheva
Radmila Kancheva
Martin HillMartin Hill
Martin Hill
ZNZ. Novák
Z. Novák
JCJ. Chrastina
J. Chrastina
LKL. Kancheva
L. Kancheva
LSL. Stárka
L. Stárka

1 March 2010 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
RKRadmila Kancheva
Radmila Kancheva
Martin HillMartin Hill
Martin Hill
ZNZdeněk Novák
Zdeněk Novák
JCJan Chrastina
Jan Chrastina
MVMarta Velíková
Marta Velíková
LSLuboslav Stárka
Luboslav Stárka

1 April 2016 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
MVMarkéta Vaňková
Markéta Vaňková
Martin HillMartin Hill
Martin Hill
MVMarta Velíková
Marta Velíková
JVJosef Vcelak
Josef Vcelak
GVGabriela Vacínová
Gabriela Vacínová
LSLuboslav Stárka
Luboslav Stárka

Verified
Journal Article
Open access
PDF file
PHPavla Honců
Pavla Honců
Martin HillMartin Hill
Martin Hill
MBMarie Bicikova
Marie Bicikova
DJDobroslava Jandová
Dobroslava Jandová
MVMarta Velíková
Marta Velíková
ĽSĽuboslav Stárka
Ľuboslav Stárka
Spa treatment can effectively reestablish mood balance in patients with psychiatric disorders. In light of the adrenal gland’s role as a crossroad of psychosomatic medicine, this study evaluated changes in 88 circulating steroids and their relationships with a consolidation of somatic, psychosomatic and psychiatric components from a modified N-5 neurotic questionnaire in 46 postmenopausal 50+ women with anxiety-depressive complaints. The patients underwent a standardized one-month intervention therapy with physical activity and an optimized daily regimen in a spa in the Czech Republic. All participants were on medication with selective serotonin reuptake inhibitors. An increase of adrenal steroidogenesis after intervention indicated a reinstatement of the hypothalamic-pituitary-adrenal axis. The increases of many of these steroids were likely beneficial to patients, including immunoprotective adrenal androgens and their metabolites, neuroactive steroids that stimulate mental activity but protect from excitotoxicity, steroids that suppress pain perception and fear, steroids that consolidate insulin secretion, and steroids that improve xenobiotic clearance. The positive associations between the initial values of neurotic symptoms and their declines after the intervention, as well as between initial adrenal activity and the decline of neurotic symptoms, indicate that neurotic impairment may be alleviated by such therapy provided that the initial adrenal activity is not seriously disrupted.

Verified
Journal Article
Open access
PDF file
RKRadmila Kancheva
Radmila Kancheva
Martin HillMartin Hill
Martin Hill
MVMarta Velíková
Marta Velíková
LKLudmila Kancheva
Ludmila Kancheva
JVJosef Vcelak
Josef Vcelak
EHEva Kubala Havrdová
Eva Kubala Havrdová
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) mainly afflicting young women. Various steroids can influence the onset and development of the disease or, on the contrary, mitigate its course; however, a systematic review of steroidomic changes in MS patients is lacking. Based on the gas chromatography tandem mass spectrometry (GC-MS/MS) platform and, in the case of estradiol, also using immunoassay, this study performed a comprehensive steroidomic analysis in 25 female MS patients aged 39(32, 49) years compared to 15 female age-matched controls aged 38(31, 46) years. A significant trend towards higher ratios of conjugated steroids to their unconjugated counterparts was found in patients, which is of particular interest in terms of the balance between excitatory and inhibitory steroid modulators of ionotropic receptors. Patients showed altered metabolic pathway to cortisol with decreased conversion of pregnenolone to 17-hydroxypregnenolone and 17-hydroxypregnenolone to 17-hydroxyprogesterone and increased conversion of 17-hydroxypregnenolone to dehydroepiandrosterone (DHEA), resulting in lower levels of 17-hydroxyprogesterone, as well as indications of impaired conversion of 11-deoxy-steroids to 11β-hydroxy-steroids but reduced conversion of cortisol to cortisone. Due to over-activation of hypothalamic-pituitary-adrenal axis (HPAA), however, cortisol and cortisone levels were higher in patients with indications of depleted cortisol synthesizing enzymes. Patients showed lower conversion of DHEA to androstenedione, androstenedione to testosterone, androstenedione to estradiol in the major pathway, and testosterone to estradiol in the minor pathway for estradiol synthesis at increased conversion of androstenedione to testosterone. They also showed lower conversion of immunoprotective Δ5 androstanes to their more potent 7α/β-hydroxy metabolites and had lower circulating allopregnanolone and higher ratio 3β-hydroxy-steroids to their neuroprotective 3α-hydroxy-counterparts.

23 November 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
LOLeona Ondřejíková
Leona Ondřejíková
APAntonín Pařízek
Antonín Pařízek
PŠPatrik Šimják
Patrik Šimják
DVDaniela Vejrazkova
Daniela Vejrazkova
MVMarta Velíková
Marta Velíková
Martin HillMartin Hill
Martin Hill
Gestational diabetes mellitus (GDM) is a complication in pregnancy, but studies focused on the steroidome in patients with GDM are not available in the public domain. This article evaluates the steroidome in GDM+ and GDM− women and its changes from 24 weeks (± of gestation) to labor. The study included GDM+ (n = 44) and GDM− women (n = 33), in weeks 24–28, 30–36 of gestation and at labor and mixed umbilical blood after delivery. Steroidomic data (101 steroids quantified by GC-MS/MS) support the concept that the increasing diabetogenic effects with the approaching term are associated with mounting progesterone levels. The GDM+ group showed lower levels of testosterone (due to reduced AKR1C3 activity), estradiol (due to a shift from the HSD17B1 towards HSD17B2 activity), 7-oxygenated androgens (competing with cortisone for HSD11B1 and shifting the balance from diabetogenic cortisol towards the inactive cortisone), reduced activities of SRD5As, and CYP17A1 in the hydroxylase but higher CYP17A1 activity in the lyase step. With the approaching term, the authors found rising activities of CYP3A7, AKR1C1, CYP17A1 in its hydroxylase step, but a decline in its lyase step, rising conjugation of neuroinhibitory and pregnancy-stabilizing steroids and weakening AKR1D1 activity.